300
Participants
Start Date
August 14, 2024
Primary Completion Date
August 30, 2025
Study Completion Date
December 30, 2025
ZT002 Injection
Administered SC
ZT002 Placebo
Administered SC
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
Genertec Liaoyou Gem Flower Hospital, Panjin
Tonghua Central Hospital, Tonghua
The Fourth Affiliated Hospital Harbin Medical University, Harbin
Nanjing Jiangning Hospital, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
Central Hospital Affiliated to Shandong First Medical University, Jinan
Zibo Municipal Hospital, Zibo
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
Luoyang Third People's Hospital, Luoyang
The First Affiliated of Nanyang Medical College, Nanyang
Xi'an Daxing Hospital, Xi’an
Handan First Hospital, Handan
Hebei Petro China Cental Hospital, Langfang
First Hospital of Qinhuangdao, Qinhuangdao
Lead Sponsor
Beijing QL Biopharmaceutical Co.,Ltd
INDUSTRY